New York Cancer & Blood Specialists successfully challenged the New York State Department of Health’s restrictive definition of “oncologic protocol.”
UF Health officials and supporters gathered Wednesday to unveil the UF Health Cancer Center’s Mobile Cancer Screening Connector, which will take cancer screening care to a 23-county area in North Florida. UF Health photo by Nate GuidryThe University of Florida Health Cancer Center launched a 40-foot-long mobile cancer screening bus that will expand access to cancer screenings and essential health care services, including 3D mammograms and cervical, colon, and prostate cancer screenings.
The University of New Mexico Comprehensive Cancer Center has received reaccreditation from the Commission on Cancer, a quality program of the American College of Surgeons.
The University of Hawai‘i Cancer Center has received a full five-year designation from NCI.
ECOG-ACRIN Cancer Research Group and Caris Life Sciences announced a multi-year research collaboration wherein Caris is pairing its genomic, transcriptomic, and proteomic profiling, advanced artificial intelligence and machine learning algorithms with ECOG-ACRIN’s research capabilities.
Modifi Biosciences Inc., a Yale University spinout company formed in 2021 that develops direct DNA-modification-enabled cancer therapeutics, has been acquired by Merck.
Marshall Posner, physician-scientist and head-and-neck oncologist, joined TGH Cancer Institute | Cancer Center of South Florida, effective Oct. 1.
Greg Sawyer, chair of the bioengineering department at Moffitt Cancer Center, has been awarded the 2023 Tribology Gold Medal by the International Tribology Council. This prestigious award is the highest honor in the field and recognizes individuals who have made extraordinary lifetime contributions to the study of friction, wear, and lubrication.
Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.
Kate Hitchcock, a UF Health radiation oncologist and an associate professor in the Department of Radiation Oncology in the UF College of Medicine, has been named associate director for access and opportunities at the UF Health Cancer Center. In this role, she will use her experience in leading clinical trials and broad range of healthcare experience to help the center train the next generation of cancer researchers, preparing them to lead advancements in the field.
